ATF3 and colorectal carcinoma: Since ATF3 is highly expressed in QCCs, further study of this finding may help us better understand the behavior of QCCs, and certain treatments that impair ATF3-enhanced cytoprotection may improve the outcome of CRC treatment, such as the combination of 5-FU with rapamycin or torin-1 investigated in this study.